Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-21 Sale | 2024-02-23 8:12 pm | Kronos Bio Inc. | KRON | Olek Elizabeth A SR VP, CLINICAL SCIENCE | 7,368 | $1.0539 | $7,765 | 193,275 (Direct) | View |
| 2024-02-21 Sale | 2024-02-23 8:07 pm | Kronos Bio Inc. | KRON | Lin Charles Y SR VP, RESEARCH & DEVELOPMENT | 12,036 | $1.0539 | $12,685 | 234,603 (Direct) | View |
| 2024-02-21 Sale | 2024-02-23 8:04 pm | Kronos Bio Inc. | KRON | Frisbee Allison SR VP, CORP OPERATIONS & LEGAL | 12,105 | $1.0539 | $12,757 | 204,510 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 6:30 pm | Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer | 7,366 | $1.1836 | $8,718 | 260,969 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 6:27 pm | Kronos Bio Inc. | KRON | DiMartino Jorge Chief Medical Officer & VP | 12,009 | $1.1836 | $14,214 | 315,246 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 6:26 pm | Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel | 10,676 | $1.1836 | $12,636 | 928,966 (Direct) | View |
| 2023-12-12 Sale | 2023-12-13 4:10 pm | Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer | 10,032 | $1.305 | $13,092 | 268,335 (Direct) | View |
| 2023-12-12 Sale | 2023-12-13 4:09 pm | Kronos Bio Inc. | KRON | DiMartino Jorge Chief Medical Officer & VP | 17,367 | $1.305 | $22,664 | 327,255 (Direct) | View |
| 2023-11-15 Purchase | 2023-11-17 5:41 pm | Kronos Bio Inc. | KRON | BISCHOFBERGER NORBERT W President & CEO | 1,731,056 | $0.84942 | $1,470,395 | 7,966,159 (Indirect Direct) | View |
| 2023-07-06 Sale | 2023-07-07 4:08 pm | Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer | 6,634 | $1.7523 | $11,625 | 278,367 (Direct) | View |
| 2023-07-06 Sale | 2023-07-07 4:07 pm | Kronos Bio Inc. | KRON | DiMartino Jorge Chief Medical Officer & VP | 10,818 | $1.7523 | $18,956 | 344,622 (Direct) | View |
| 2023-07-06 Sale | 2023-07-07 4:06 pm | Kronos Bio Inc. | KRON | Al-Wakeel Yasir B. Chief Financial Officer | 9,617 | $1.7523 | $16,852 | 346,102 (Direct) | View |
| 2023-02-24 Sale | 2023-02-24 9:36 pm | Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer | 6,291 | $1.7355 | $10,918 | 285,001 (Direct) | View |
| 2023-02-24 Sale | 2023-02-24 9:35 pm | Kronos Bio Inc. | KRON | DiMartino Jorge Chief Medical Officer & VP | 10,153 | $1.7355 | $17,621 | 355,440 (Direct) | View |
| 2023-02-24 Sale | 2023-02-24 9:34 pm | Kronos Bio Inc. | KRON | Al-Wakeel Yasir B. Chief Financial Officer | 9,026 | $1.7355 | $15,665 | 355,719 (Direct) | View |
| 2022-12-12 Sale | 2022-12-14 4:35 pm | Kronos Bio Inc. | KRON | DiMartino Jorge Chief Medical Officer & VP | 18,657 | $1.8052 | $33,680 | 219,478 (Direct) | View |
| 2022-12-12 Sale | 2022-12-14 4:31 pm | Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer | 9,138 | $1.8052 | $16,496 | 162,936 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-02-23 8:09 pm | N/A N/A | Kronos Bio Inc. | KRON | Olek Elizabeth A SR VP, CLINICAL SCIENCE | 0 | $0 | 610,558 (Direct) | View |
Ownership | 2024-02-23 8:06 pm | N/A N/A | Kronos Bio Inc. | KRON | Lin Charles Y SR VP, RESEARCH & DEVELOPMENT | 0 | $0 | 721,859 (Direct) | View |
Ownership | 2024-02-23 8:03 pm | N/A N/A | Kronos Bio Inc. | KRON | Frisbee Allison SR VP, CORP OPERATIONS & LEGAL | 0 | $0 | 589,320 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 8:34 pm | N/A 2034-02-14 | Kronos Bio Inc. | KRON | BISCHOFBERGER NORBERT W PRESIDENT & CEO | 970,139 | $0 | 8,936,298 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:15 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | Ridloff Elena Director | 28,333 | $0 | 30,963 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:14 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | DANSEY ROGER D Director | 5,868 | $0 | 5,868 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:14 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | Stultz Katherine V Director | 7,079 | $0 | 7,079 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:13 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | Yang Taiyin Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:12 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | Blunt Roshawn A. Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:11 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | De Backer Marianne Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:09 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | Kazam Joshua A Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:08 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | TANEN DAVID M Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:08 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | Belldegrun Arie Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-04-20 Option Award | 2023-04-24 4:22 pm | N/A 2033-04-19 | Kronos Bio Inc. | KRON | DANSEY ROGER D Director | 68,000 | $0 | 68,000 (Direct) | View |
| 2023-04-10 Option Award | 2023-04-11 4:40 pm | N/A 2033-04-09 | Kronos Bio Inc. | KRON | Stultz Katherine V Director | 68,000 | $0 | 68,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:21 pm | N/A 2033-02-14 | Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer | 299,706 | $0 | 471,116 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:19 pm | N/A 2033-02-14 | Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel | 347,278 | $0 | 1,148,009 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:18 pm | N/A 2033-02-14 | Kronos Bio Inc. | KRON | DiMartino Jorge Chief Medical Officer & VP | 342,521 | $0 | 571,106 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:16 pm | N/A 2033-02-14 | Kronos Bio Inc. | KRON | Al-Wakeel Yasir B. Chief Financial Officer | 347,278 | $0 | 573,112 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:14 pm | N/A 2033-02-14 | Kronos Bio Inc. | KRON | BISCHOFBERGER NORBERT W President & CEO | 570,868 | $0 | 6,805,971 (Direct) | View |